Biological processes for the production of aryl sulfates
The present invention generally relates to the field of biotechnology as it applies to the production of aryl sulfates using polypeptides or recombinant cells comprising said polypeptides. More particularly, the present invention pertains to polypeptides having aryl sulfotransferase activity, recombinant host cells expressing same and processes for the production of aryl sulfates employing these polypeptides or recombinant host cells.
1. A process for the production of a sulfated phenolic compound comprising:
contacting a medium comprising a phenolic compound or a precursor of a phenolic compound with a recombinant host cell which comprises a heterologous polypeptide having an aryl sulfotransferase activity;
wherein the phenolic compound is represented by the general formula (I):
and the precursor of a phenolic compound is a compound of the general Formula (p-I):
wherein R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are independently selected from the group consisting of halide, hydrogen, hydroxyl (—OH), —OR 7 , —OCOR 7 , —NR 7 Its, —COR 7 , —COOR 7 , —SR7, —OSO 3 R 7 , —OCSR 7 , —POR 7 R 8 , alkyl, alkenyl, alkynyl, aryl, and heteroaryl; wherein R 7 , and R 8 are independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, aryl, and heteroaryl; wherein at least one of R 1 , R 2 , R 3 , R 4 , and R 5 is a hydroxyl group (—OH);
wherein the recombinant host cell is a bacterium or yeast; and
wherein the polypeptide having the aryl sulfotransferase activity is selected from the group consisting of:
a) a polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 or 13; and
b) a polypeptide comprising an amino acid sequence which has at least about 95% sequence identity to the amino acid sequence set forth in SEQ ID NO: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 or 13, wherein the polypeptide has aryl sulfotransferase activity.
2. The process according to claim 1 , wherein the recombinant host cell is a bacterium.
3. The process according to claim 1 , wherein the recombinant host cell is a bacterium of the genus Bacillus, Lactococcus, Lactobacillus, Clostridium, Corynebacterium, Geobacillus, Thermoanaerobacterium, Streptococcus, Pseudomonas, Streptomyces, Escherichia, Shigella, Acinetobacter, Citrobacter, Salmonella, Klebsiella, Enterobacter, Erwinia, Kluyvera, Serratia, Cedecea, Morganella, Hafnia, Edwardsiella, Providencia, Proteus , or Yersinia ; or wherein the first recombinant host cell is a yeast of the genus Saccharomyces, Pichia, Schizosacharomyces, Zygosaccharomyces, Hansenula, Pachyosolen, Kluyveromyces, Debaryomyces, Yarrowia, Candida, Cryptococcus, Komagataella, Lipomyces , Rhodospiridium, Rhodotorula , or Trichosporon.
4. The process according to claim 1 , wherein the recombinant host cell is a bacterium of the genus Escherichia.
5. The process according to claim 1 , where the recombinant host cell is a bacterium of the species Escherichia coli.
6. The process according to claim 1 , wherein the recombinant host cell has been modified to have an increased protein expression of an ATP sulfurylase as compared to an identical host cell that does not carry said modification.
7. The process according to claim 1 , wherein the recombinant host cell has been further modified to have an increased expression of an APS kinase protein as compared to an identical host cell that does not carry said modification.
8. The process according to claim 1 , wherein the recombinant host cell has been further modified to have an increased expression of a PAP phosphatase protein as compared to an identical host cell that does not carry said modification.
9. The process according to claim 1 , wherein the recombinant host cell has been further modified to have an increased protein expression of a ATP sulfurylase and a APS kinase as compared to an identical host cell that does not carry said modification.
10. The process according to claim 1 , wherein the recombinant host cell has been further modified to have an increased protein expression of a ATP sulfurylase and a PAP phosphatase as compared to an identical host cell that does not carry said modification.
11. The process according to claim 1 , wherein the recombinant host cell has been further modified to have an increased protein expression of a APS kinase and a PAP phosphatase as compared to an identical host cell that does not carry said modification.
12. The process according to claim 1 , wherein the recombinant host cell has been further modified to have an increased protein expression of a ATP sulfurylase, a APS kinase and a PAP phosphatase as compared to an identical host cell that does not carry said modification.
13. The process according to claim 1 , wherein R 6 is —COOH.
14. The process according to claim 1 , wherein R 3 is hydroxyl (—OH).
15. The process according to claim 1 , wherein each of R 1 , R 3 and R 5 is hydrogen, each of R 2 and R 4 is hydroxyl, and R 6 is p-hydroxyphenyl.
16. The process according to claim 1 , wherein each of R 1 , R 2 , R 4 , R 5 and R 6 is hydrogen, and R 3 is hydroxyl.
17. The process according to claim 1 , wherein R 1 is hydrogen; R 2 , R 3 and R 4 independently are selected from the group consisting of hydrogen, hydroxyl, C 1-6 -alkyl and C 1-6 -alkoxy, provided that at least one of R 2 , R 3 and R 4 is hydroxyl (—OH); R 5 is hydrogen, and R 6 is COOH.
18. The process according to claim 1 , wherein each of R 1 , R 2 , R 4 and R 5 is hydrogen, R 3 is hydroxyl, and R 6 is COOH.